These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32556806)

  • 1. Efficient affinity ranking of fluorinated ligands by
    Rüdisser SH; Goldberg N; Ebert MO; Kovacs H; Gossert AD
    J Biomol NMR; 2020 Nov; 74(10-11):579-594. PubMed ID: 32556806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects.
    Dalvit C; Vulpetti A
    J Med Chem; 2019 Mar; 62(5):2218-2244. PubMed ID: 30295487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The precious fluorine on the ring: fluorine NMR for biological systems.
    Boeszoermenyi A; Ogórek B; Jain A; Arthanari H; Wagner G
    J Biomol NMR; 2020 Sep; 74(8-9):365-379. PubMed ID: 32651751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine.
    Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C
    J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-correlated (19)F relaxation measurements for the study of fluorinated ligand-receptor interactions.
    Peng JW
    J Magn Reson; 2001 Nov; 153(1):32-47. PubMed ID: 11700079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to
    Urick AK; Calle LP; Espinosa JF; Hu H; Pomerantz WC
    ACS Chem Biol; 2016 Nov; 11(11):3154-3164. PubMed ID: 27627661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spin-lattice relaxation time in drug discovery and design.
    Figueroa-Villar JD; Tinoco LW
    Curr Top Med Chem; 2009; 9(9):811-23. PubMed ID: 19754396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Ligand-Binding Affinity (
    Liu M; Mirza A; McAndrew PC; Thapaliya A; Pierrat OA; Stubbs M; Hahner T; Chessum NEA; Innocenti P; Caldwell J; Cheeseman MD; Bellenie BR; van Montfort RLM; Newton GK; Burke R; Collins I; Hoelder S
    J Med Chem; 2023 Aug; 66(15):10617-10627. PubMed ID: 37467168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 3F Library: Fluorinated Fsp
    Troelsen NS; Shanina E; Gonzalez-Romero D; Danková D; Jensen ISA; Śniady KJ; Nami F; Zhang H; Rademacher C; Cuenda A; Gotfredsen CH; Clausen MH
    Angew Chem Int Ed Engl; 2020 Feb; 59(6):2204-2210. PubMed ID: 31724281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR screening method based on
    Furihata K; Tashiro M
    Anal Sci; 2024 Jan; 40(1):219-223. PubMed ID: 37838626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine-NMR competition binding experiments for high-throughput screening of large compound mixtures.
    Dalvit C; Flocco M; Veronesi M; Stockman BJ
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):605-11. PubMed ID: 12470257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and generation of highly diverse fluorinated fragment libraries and their efficient screening with improved (19) F NMR methodology.
    Vulpetti A; Dalvit C
    ChemMedChem; 2013 Dec; 8(12):2057-69. PubMed ID: 24127294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear magnetic resonance of hyperpolarized fluorine for characterization of protein-ligand interactions.
    Lee Y; Zeng H; Ruedisser S; Gossert AD; Hilty C
    J Am Chem Soc; 2012 Oct; 134(42):17448-51. PubMed ID: 23020226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating protein-ligand binding affinity using high-throughput screening by NMR.
    Shortridge MD; Hage DS; Harbison GS; Powers R
    J Comb Chem; 2008; 10(6):948-58. PubMed ID: 18831571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 19F NMR spectroscopy to screen chemical libraries for ligands that bind to proteins.
    Tengel T; Fex T; Emtenas H; Almqvist F; Sethson I; Kihlberg J
    Org Biomol Chem; 2004 Mar; 2(5):725-31. PubMed ID: 14985813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity screening using competitive binding with fluorine-19 hyperpolarized ligands.
    Kim Y; Hilty C
    Angew Chem Int Ed Engl; 2015 Apr; 54(16):4941-4. PubMed ID: 25703090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of (19)F-NMR in Fragment-Based Drug Discovery.
    Norton RS; Leung EW; Chandrashekaran IR; MacRaild CA
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ¹⁹F nuclear magnetic resonance screening of glucokinase activators.
    Assemat O; Antoine M; Fourquez JM; Wierzbicki M; Charton Y; Hennig P; Perron-Sierra F; Ferry G; Boutin JA; Delsuc MA
    Anal Biochem; 2015 May; 477():62-8. PubMed ID: 25684110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current NMR Techniques for Structure-Based Drug Discovery.
    Sugiki T; Furuita K; Fujiwara T; Kojima C
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29329228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.